
Highlights From the 2023 American Society of Clinical Oncology Annual Meeting
JAMA Medical News
00:00
The Potential Benefits of Nivolomab Immunotherapy for Patients With Advanced Hodgical Lymphoma
Only six patients in the entire trial needed that extra radiation boost after treatment. The benefit of the nivolomab was seen across all subgroups, every place that they stratified old versus young. It looks like this may be heading toward potential new standard of care treatment.
Transcript
Play full episode